World's Best Scientists 2026 revealed!
Claude Preudhomme

Claude Preudhomme

D-Index & Metrics

Medicine

D-Index
103
Citations
38250
World Ranking
7378
National Ranking
228

Overview

Claude Preudhomme is affiliated with the University of Lille in France. Their research primarily lies within the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on subfields such as Hematology, Genetics, Molecular Biology, Immunology, and Cancer Research.

Their scholarly work covers several key topics including:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Acute Lymphoblastic Leukemia Research
  • Histone Deacetylase Inhibitors Research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research

Preudhomme's publication record includes numerous articles in frequent venues such as:

  • Blood
  • Leukemia
  • Blood Advances
  • British Journal of Haematology
  • Haematologica

Among their recent publications are:

  • 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party, 2021, Blood
  • A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia, 2022, Nature Medicine
  • Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience, 2021, Blood Advances
  • The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants, 2020, Nature Communications
  • Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results, 2020, Blood Advances

Frequent collaborators in Preudhomme's research include:

  • Nicolas Duployez
  • Hervé Dombret
  • Laurène Fenwarth
  • Raphaël Itzykson
  • Céline Berthon

Best Publications

  • A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

    Pierre Fenaux;Claude Chastang;Sylvie Chevret;Miguel Sanz

  • Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

    Sylvie Castaigne;Cécile Pautas;Christine Terré;Emmanuel Raffoux

  • Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

    Gerrit J. Schuurhuis;Michael Heuser;Sylvie Freeman;Marie Christine Béne

  • A 17-gene stemness score for rapid determination of risk in acute leukaemia

    Stanley W. K. Ng;Amanda Mitchell;James A. Kennedy;James A. Kennedy;James A. Kennedy;Weihsu C. Chen

  • p53 Mutations Are Associated With Resistance to Chemotherapy and Short Survival in Hematologic Malignancies

    Eric Wattel;Claude Preudhomme;Bernard Hecquet;Michael Vanrumbeke

  • Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment

    Catherine Roche-Lestienne;Valerie Soenen-Cornu;Nathalie Grardel-Duflos;Jean-Luc Laı̈

  • Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).

    Claude Preudhomme;Christophe Sagot;Nicolas Boissel;Jean-Michel Cayuela

  • Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study

    Daniel Cilloni;Aline Renneville;Fabienne Hermitte;Robert Kerrin Hills

  • Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

    R Itzykson;O Kosmider;T Cluzeau;V Mansat-De Mas

  • Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

    Raphaël Itzykson;Olivier Kosmider;Aline Renneville;Véronique Gelsi-Boyer

  • Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion.

    Yvon Sterkers;Claude Preudhomme;Jean-Luc Laı̈;Jean-Loup Demory

  • Cooperating gene mutations in acute myeloid leukemia: a review of the literature

    A Renneville;C Roumier;V Biggio;O Nibourel

  • Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.

    Claude Preudhomme;Joëlle Guilhot;Franck Emmanuel Nicolini;Agnès Guerci-Bresler

  • 2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document.

    Michael Heuser;Sylvie D Freeman;Gert J Ossenkoppele;Francesco Buccisano

  • Methylation of the p15INK4b Gene in Myelodysplastic Syndromes Is Frequent and Acquired During Disease Progression

    Bruno Quesnel;Gaelle Guillerm;Rodolphe Vereecque;Eric Wattel

  • Incidence and prognostic impact of c-Kit , FLT3 , and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

    N Boissel;H Leroy;B Brethon;N Philippe

  • Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases

    P. Morel;Mohamed Hebbar;J.-L. Lai;A. Duhamel

  • Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

    Céline Berthon;Emmanuel Raffoux;Xavier Thomas;Norbert Vey

  • Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

    Eric Jourdan;Nicolas Boissel;Sylvie Chevret;Eric Delabesse

  • TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

    Olivier Kosmider;Véronique Gelsi-Boyer;Meyling Cheok;Sophie Grabar

Frequent Co-Authors

Pierre Fenaux
Pierre Fenaux Université Paris Cité
Aline Renneville
Aline Renneville Institut Gustave Roussy
Hervé Dombret
Hervé Dombret Université Paris Cité
Nicolas Boissel
Nicolas Boissel Université Paris Cité
Sylvie Castaigne
Sylvie Castaigne Versailles Saint-Quentin-en-Yvelines University
Emmanuel Raffoux
Emmanuel Raffoux Hôpital Saint-Louis
Stéphane de Botton
Stéphane de Botton Institut Gustave Roussy
Sylvie Chevret
Sylvie Chevret Université Paris Cité
Michaela Fontenay
Michaela Fontenay Institut Cochin
Elizabeth Macintyre
Elizabeth Macintyre Necker-Enfants Malades Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine, there are several online degree options and pathways that can expand your opportunities in healthcare. For those interested in mental health, pursuing the fastest pmhnp program online allows you to become a Psychiatric Mental Health Nurse Practitioner more quickly and flexibly than traditional routes.

Healthcare leadership roles are also in demand. Earning a health care administration online degree can open doors to management positions in hospitals, clinics, and health organizations. For cost-conscious students, the cheapest master's in healthcare administration offers an affordable path to an advanced credential in the field.

If you already have a nursing background, advancing your qualifications through msn to dnp programs online can help you achieve the highest level of nursing practice, opening up further career advancements and higher earning potential.

Exploring these online degree choices can help you find a medical or healthcare career path that aligns with your goals, budget, and schedule.

Best Scientists Citing Claude Preudhomme

Trending Scientists